We are live on
!
Find out more
CC
Colrain Capital Portfolio holdings
AUM
$259M
1-Year Est. Return
63.6%
This Fund
S&P 500
This Quarter
Est. Return
+12.11%
1 Year Est. Return
+63.6%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$83.1M
AUM Growth
+$29.7M
(+56%)
Cap. Flow
+$4.57M
Cap. Flow
% of AUM
5.49%
Top 10 Holdings %
Top 10 Hldgs %
71.5%
Holding
25
New
2
Increased
12
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$1.28M |
| 2 |
Medtronic
MDT
|
+$579K |
| 3 |
Newmont
NEM
|
+$567K |
| 4 |
Comcast
CMCSA
|
+$558K |
| 5 |
Citigroup
C
|
+$532K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$1.26M |
| 2 |
Microsoft
MSFT
|
+$81.1K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 28.37% |
| 2 | Healthcare | 18.45% |
| 3 | Technology | 12.2% |
| 4 | Materials | 11.61% |
| 5 | Communication Services | 8.46% |
Similar funds
NAM
CCAM
QP
BFA
PW
BFP
TC
FC
Colrain Capital's Q4 2021 Portfolio in Review
As of Q4 2021, Colrain Capital held 25 positions worth $83.1M, up 56% from $53.4M the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Colrain Capital deployed $4.57M of net new capital in Q4 2021, opening 2 new positions and adding to 12 existing holdings. Its largest new stake was Dow Inc: 22,500 shares worth $1.28M.
By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 7.6% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Hess, an estimated $1.26M trimmed.
- Colrain Capital's largest Q4 2021 buy was Dow Inc: 22,500 shares worth $1.28M.
- Colrain Capital added most to Medtronic in Q4 2021, an estimated $579K increase.
- Colrain Capital's biggest Q4 2021 reduction was Hess, cutting an estimated $1.26M.
- Colrain Capital's ten largest holdings make up 71% of its $83.1M portfolio in Q4 2021.
- Colrain Capital opened 2 new positions and closed 0 in Q4 2021.
- Colrain Capital's portfolio value rose 56% quarter-over-quarter to $83.1M.
Based on Colrain Capital's 13F filing for Q4 2021, filed 7 Feb 2022.